Financial summary
Two-year summary - Year ended 30 June 2007
| Year ended 30 June 2007 £'000 |
Period from 18 July 2005 to 30 June 2006 £'000 |
|
|---|---|---|
| Results | ||
| Operating loss | (3,556) | (363) |
| Loss before tax | (3,236) | (363) |
| Loss attributable to equity holders of Neuropharm Group plc | (3,236) | (363) |
| Assets employed | ||
| Non-current assets | 59 | - |
| Current assets | 18,109 | 570 |
| Current liabilities | (1,365) | (146) |
| Non-current liabilities | (101) | - |
| Net assets | 16,702 | 424 |
| Financed by | ||
| Equity | 16,702 | 424 |
| Key statistics | ||
| Basic and diluted loss per share | (16.6)p | (8.7)p |